The matrix metalloproteinase inhibitor IPR-179 has antiseizure and antiepileptogenic effects.
Broekaart DW, Bertran A, Jia S, Korotkov A, Senkov O, Bongaarts A, Mills JD, Anink JJ, Seco J, Baayen JC, Idema S, Chabrol E, Becker AJ, Wadman WJ, Tarragó T, Gorter JA, Aronica E, Prades R, Dityatev A, van Vliet EA.
Broekaart DW, et al. Among authors: chabrol e.
J Clin Invest. 2021 Jan 4;131(1):e138332. doi: 10.1172/JCI138332.
J Clin Invest. 2021.
PMID: 33141761
Free PMC article.